Skip to content

Evommune EVMN Total Operating Expenses

Total Operating Expenses at other companies

BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$61.26M+52.1%
Perrigo Company logo
Perrigo CompanyPRGO
$697.8M+102%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$475.11M+27.4%

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+39.5%
Enterprise value$849.52M
P/S127.3×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's total operating expenses?
Evommune (EVMN) reported total operating expenses of $1.64M in Q1 2026.
How has Evommune 's total operating expenses changed year-over-year?
Evommune 's total operating expenses increased by 82.9% year-over-year, from $898.86K to $1.64M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.